» Articles » PMID: 27231894

Cardiac Stem Cell Secretome Protects Cardiomyocytes from Hypoxic Injury Partly Via Monocyte Chemotactic Protein-1-Dependent Mechanism

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2016 May 28
PMID 27231894
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac stem cells (CSCs) were known to secrete diverse paracrine factors leading to functional improvement and beneficial left ventricular remodeling via activation of the endogenous pro-survival signaling pathway. However, little is known about the paracrine factors secreted by CSCs and their roles in cardiomyocyte survival during hypoxic condition mimicking the post-myocardial infarction environment. We established Sca-1+/CD31- human telomerase reverse transcriptase-immortalized CSCs (Sca-1+/CD31- CSCs(hTERT)), evaluated their stem cell properties, and paracrine potential in cardiomyocyte survival during hypoxia-induced injury. Sca-1+/CD31- CSCs(hTERT) sustained proliferation ability even after long-term culture exceeding 100 population doublings, and represented multi-differentiation potential into cardiomyogenic, endothelial, adipogenic, and osteogenic lineages. Dominant factors secreted from Sca-1+/CD31- CSCs(hTERT) were EGF, TGF-β1, IGF-1, IGF-2, MCP-1, HGF R, and IL-6. Among these, MCP-1 was the most predominant factor in Sca-1+/CD31- CSCs(hTERT) conditioned medium (CM). Sca-1+/CD31- CSCs(hTERT) CM increased survival and reduced apoptosis of HL-1 cardiomyocytes during hypoxic injury. MCP-1 silencing in Sca-1+/CD31- CSCs(hTERT) CM resulted in a significant reduction in cardiomyocyte apoptosis. We demonstrated that Sca-1+/CD31- CSCs(hTERT) exhibited long-term proliferation capacity and multi-differentiation potential. Sca-1+/CD31- CSCs(hTERT) CM protected cardiomyocytes from hypoxic injury partly via MCP-1-dependent mechanism. Thus, they are valuable sources for in vitro and in vivo studies in the cardiovascular field.

Citing Articles

Immortalized mesenchymal stromal cells overexpressing alpha-1 antitrypsin protect acinar cells from apoptotic and ferroptotic cell death.

Shoeibi S, Green E, Wei H, Gou W, Strange C, Wang H J Cell Mol Med. 2024; 28(20):e70093.

PMID: 39468387 PMC: 11518823. DOI: 10.1111/jcmm.70093.


Development of a + Cardiac Mouse Progenitor Immortalized Model to Unravel the Relationship with Its Protective Vascular Endothelial Niche.

Albericio G, Higuera M, Araque P, Sanchez C, Herrero D, Garcia-Brenes M Int J Mol Sci. 2024; 25(16).

PMID: 39201501 PMC: 11354400. DOI: 10.3390/ijms25168815.


Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives.

Voloshin N, Tyurin-Kuzmin P, Karagyaur M, Akopyan Z, Kulebyakin K Int J Mol Sci. 2023; 24(16).

PMID: 37628897 PMC: 10454025. DOI: 10.3390/ijms241612716.


Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells.

Antonelli A, Scarpa E, Bruzzone S, Astigiano C, Piacente F, Bruschi M Int J Mol Sci. 2023; 24(6).

PMID: 36982232 PMC: 10049254. DOI: 10.3390/ijms24065157.


Effects of Cardiotoxins on Cardiac Stem and Progenitor Cell Populations.

Smith A Front Cardiovasc Med. 2021; 8:624028.

PMID: 33987210 PMC: 8110700. DOI: 10.3389/fcvm.2021.624028.


References
1.
Balducci L, Blasi A, Saldarelli M, Soleti A, Pessina A, Bonomi A . Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors. Stem Cell Res Ther. 2014; 5(3):63. PMC: 4055112. DOI: 10.1186/scrt452. View

2.
Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban M . Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation. 2003; 107(19):2428-34. DOI: 10.1161/01.CIR.0000066907.83923.32. View

3.
Freire A, Nascimento D, Forte G, Valente M, Resende T, Pagliari S . Stable phenotype and function of immortalized Lin-Sca-1+ cardiac progenitor cells in long-term culture: a step closer to standardization. Stem Cells Dev. 2013; 23(9):1012-26. DOI: 10.1089/scd.2013.0305. View

4.
Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy P . Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res. 2006; 99(8):891-9. DOI: 10.1161/01.RES.0000246113.82111.2d. View

5.
Ranganath S, Levy O, Inamdar M, Karp J . Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10(3):244-58. PMC: 3294273. DOI: 10.1016/j.stem.2012.02.005. View